Publication | Open Access

A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma

Vaccine SafetyTumor ImmunologyVaccine DevelopmentMedicineImmunologyTumor ImmunityPhase Ii StudyVaccine TrialTherapeutic VaccineImmunotherapeuticsImmunotherapyOncologyRadiation Oncology